Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
14.07
-0.25 (-1.75%)
At close: Sep 11, 2026, 4:00 PM EDT
13.87
-0.20 (-1.42%)
After-hours: Sep 11, 2026, 7:39 PM EDT
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.2 billion as of September 11, 2026. Its market cap has increased by 304.92% in one year.
Market Cap
1.20B
Enterprise Value
617.24M
1-Year Change
304.92%
Ranking
Category
Stock Price
$14.07
ChartMarket Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.20B, an increase of 42.00%. That is a compound annual growth rate of 6.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 1.20B | 17.56% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 1.31B |
| MannKind | 1.29B |
| MeiraGTx Holdings | 1.29B |
| Alumis | 1.28B |
| Immatics | 1.27B |
| Seaport Therapeutics | 1.24B |
| Odyssey Therapeutics | 1.23B |
| Jade Biosciences | 1.22B |